CTOs on the Move

Central Peninsula Hospital

www.cpgh.org

 
Central Peninsula Hospital, Inc., an acute care hospital, provides patient and resident centered care services serving the Central Peninsula area. It offers emergency care, anesthesia, emergency medicine, family medicine, ENT, general surgery, internal medicine, neurology, OB/GYN, ophthalmology, orthopedics, pathology, pediatrics, podiatry, psychiatry, and radiology services; and behavioral health services that include depression screenings, substance abuse treatment, and substance abuse treatment services. The company also provides imaging services that include diagnostic imaging, digital mammography examinations, computer axial tomography procedures, ultrasound/sonography, nuclear medicine, and magnetic resonance imaging; physical, occupational, speech, and massage therapy services; outpatient weight loss, walking and exercise programs, cardiac ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.cpgh.org
  • 250 Hospital Pl
    Soldotna, AK USA 99669-7559
  • Phone: 907.714.4404

Executives

Name Title Contact Details
Karl Hertz
Chief Operating Officer Profile

Similar Companies

Wellnet Healthcare

Wellnet Healthcare is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Resources

Medical Resources is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Essential HealthCare Solutions

Essential HealthCare Solutions is a Layton, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hudson Health Plan

Hudson Health Plan is a Tarrytown, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.